Premium
Corindus Vascular Robotics Inc (CVRS)
AMEX
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
At a special meeting today, stockholders of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS) approved the adoption of the Agreement and Plan of Merger (the...
Breakfast symposium and conference activities to highlight capabilities of vascular robotic technology and advancements in automation and remote treatment Corindus Vascular Robotics, Inc...
Renowned medical journal publishes the successful clinical results of remote PCI procedures using CorPath® GRX Robotic System technology Corindus Vascular Robotics, Inc. (“Corindus” or the...
SHAREHOLDER ALERT: WeissLaw LLP Investigates Corindus Vascular Robotics, Inc. PR Newswire NEW YORK, Aug. 8, 2019 NEW YORK, Aug. 8, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible...
Corindus announced today a definitive agreement to be acquired by Siemens Healthineers for approximately $1.1 billion, or $4.28 per share, in an all-cash transaction Second quarter revenue of...
-- Corindus Stockholders to Receive $4.28 Per Share -- -- All-Cash Transaction Valued at Approximately $1.1 Billion -- Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of...
Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, and David...
Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release second quarter 2019 financial and business results...
One of the nation’s largest hospital networks adopts vascular robotic technology in multiple hospital locations to treat patients in need of cardiovascular care Corindus Vascular Robotics, Inc...
Expanded indication provides access to robotic technology in vascular procedures from head to toe Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| AAPYKurv Yield Premium Strategy Apple AAPL ETF | US$ 25,7531 (0,00%) | 0 |
| AAPXT Rex 2X Long Apple Daily Target ETF | US$ 28,96 (0,00%) | 0 |
| AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | US$ 26,6125 (0,00%) | 0 |
| AAAUGoldman Sachs Physical Gold ETF Shares | US$ 27,24 (0,00%) | 0 |
| AAAAlternative Access First Priority CLO Bond ETF | US$ 25,23 (0,00%) | 0 |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
